149 related articles for article (PubMed ID: 17101596)
61. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma.
Gourin CG; Boyce BJ; Vaught CC; Burkhead LM; Podolsky RH
Laryngoscope; 2009 May; 119(5):907-14. PubMed ID: 19358195
[TBL] [Abstract][Full Text] [Related]
62. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
[TBL] [Abstract][Full Text] [Related]
63. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.
Cavalot A; Martone T; Roggero N; Brondino G; Pagano M; Cortesina G
Head Neck; 2007 Jul; 29(7):655-64. PubMed ID: 17315173
[TBL] [Abstract][Full Text] [Related]
64. [Activation markers of lymphocytes as indicators of immune system dysregulation in inflammation].
Poriadin GV; Salmasi ZhM; Kazimiskiĭ AN
Patol Fiziol Eksp Ter; 2006; (1):2-7. PubMed ID: 16607883
[TBL] [Abstract][Full Text] [Related]
65. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
Berlinger NT; Good RA
Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
[No Abstract] [Full Text] [Related]
66. Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
Young MR
Head Neck; 2006 May; 28(5):462-70. PubMed ID: 16284974
[TBL] [Abstract][Full Text] [Related]
67. Immunological mechanisms of recovery from an acute stage in patients with atopic bronchial asthma.
Poryadin GV; Zhuravleva NE; Salmasi JM; Kazimirsky AN; Semenova LY; Polner SA; Chervinskaya TA
Russ J Immunol; 2002 Oct; 7(3):259-64. PubMed ID: 12674936
[TBL] [Abstract][Full Text] [Related]
68. Infiltrating CD57+ inflammatory cells in head and neck squamous cell carcinoma: clinicopathological analysis and prognostic significance.
Fraga CA; de Oliveira MV; Domingos PL; Botelho AC; Guimarães AL; Teixeira-Carvalho A; Correa-Oliveira R; De Paula AM
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):285-90. PubMed ID: 22505010
[TBL] [Abstract][Full Text] [Related]
69. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma.
Heimdal JH; Aarstad HJ; Klementsen B; Olofsson J
Acta Otolaryngol; 1998 Nov; 118(6):887-91. PubMed ID: 9870639
[TBL] [Abstract][Full Text] [Related]
70. Immunophenotype of Peripheral Blood Lymphocytes in Patients with Burns.
Lebedev MY; Sholkina MN; Utkina TM; Vilkov SA; Korablev SB; Golubcova NV; Baryshnikov AY; Novikov VV
Russ J Immunol; 2001 Apr; 6(1):47-54. PubMed ID: 12687206
[TBL] [Abstract][Full Text] [Related]
71. CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.
Pandit R; Lathers DM; Beal NM; Garrity T; Young MR
Ann Otol Rhinol Laryngol; 2000 Aug; 109(8 Pt 1):749-54. PubMed ID: 10961808
[TBL] [Abstract][Full Text] [Related]
72. [Phenotype of peripheral blood lymphocytes in patients with lung cancer].
Oleĭnik EK; Oleĭnik VM; Bakhlaev IE; Ageenko AI
Vopr Onkol; 2001; 47(4):436-9. PubMed ID: 11710285
[TBL] [Abstract][Full Text] [Related]
73. Significance of CD44 expression in head and neck cancer: a systemic review and meta-analysis.
Chen J; Zhou J; Lu J; Xiong H; Shi X; Gong L
BMC Cancer; 2014 Jan; 14():15. PubMed ID: 24410905
[TBL] [Abstract][Full Text] [Related]
74. [The lymphocyte transformation test in squamous epithelial carcinomas of the orofacial region].
Jakobza D; Müller A; Sönnichsen N
Zahn Mund Kieferheilkd Zentralbl; 1977; 65(5):525-9. PubMed ID: 198997
[TBL] [Abstract][Full Text] [Related]
75. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma.
Heimdal JH; Kross K; Klementsen B; Olofsson J; Aarstad HJ
BMC Cancer; 2008 Jan; 8():34. PubMed ID: 18234094
[TBL] [Abstract][Full Text] [Related]
76. Dysregulation in immune functions is reflected in tumor cell cytotoxicity by peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients.
Bose A; Chakraborty T; Chakraborty K; Pal S; Baral R
Cancer Immun; 2008 Jun; 8():10. PubMed ID: 18547033
[TBL] [Abstract][Full Text] [Related]
77. Dynamic Characteristic of Surface Phenotype of Peripheral Blood Lymphocytes in Myocarditis Patients.
Poryadin GV; Sanina NP; Makarkov AI; Kazimirsky AN; Salmasi JM; Paleev PN; Paleev NR
Russ J Immunol; 1999 Jul; 4(2):165-170. PubMed ID: 12687124
[TBL] [Abstract][Full Text] [Related]
78. Flow cytometry. Tumour DNA content and prognosis in squamous cell carcinoma of the head and neck region: a review.
Richards A
Penn Dent J (Phila); 1988; 89(1):3-5. PubMed ID: 15487847
[No Abstract] [Full Text] [Related]
79. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
80. Activated and regulatory T lymphocyte populations in chronic hemodialysis patients.
Rabb H; Agosti SJ; Pollard S; Bittle PA; Ramirez G
Am J Kidney Dis; 1994 Sep; 24(3):443-52. PubMed ID: 7915875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
